10.3390/biology8020030 Biology
Of these trials, four compared DPP-4 inhibitors against placebo (SAVOR-TIMI 53, EXAMINE, TECOS, CARMELINA), eight compared GLP-1RA against placebo (ELIXA, LEADER, SUSTAIN-6, EXSCEL, HARMONY, REWIND, PIONEER 6, AMPLITUTE-O) and eleven compared SGLT-2 inhibitors against placebo (EMPA-REG, CANVAS, DECLARE, CREDENCE, DAPA-HF, DAPA CKD, VERTIS-CV, EMPEROR-R, SCORED, SOLOIST-WHF, EMPEROR-P)
Its estimated that 30% of people with type 1 diabetes will eventually develop CKD
Key benefits of Rybelsus 7 mg include: Better blood sugar control: It helps the pancreas produce more insulin when blood sugar levels are high and lower glucagon, a hormone that raises blood sugar
Tirzepatide often produces better results than semaglutide Dr
Beyond appetite suppression, GLP-1 medications may support modest improvements in insulin sensitivity and blood glucose control, which can reduce metabolic inflammation